SGC Open Notebook Project to Characterize the HMTase NSD3 Exp022 Objective: During epithelial to mesenchymal transitioning (EMT), transcription networks become activated and cytoskeletal rearrangements take place. These events promote migratory capacity and invasiveness. A common assay to measure this phenotype is wound healing. This involves plating cells and culturing until confluent at which point a scratch or wound is made in the culture. This area is imaged over a 24-72 period to monitor the rate of wound closure. Cells with increased migratory capacity will close the wound faster and are indicative of a more mesenchymal state

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.